{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:19:43Z","timestamp":1786439983038,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.hrthm.2016.03.049","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T15:31:16Z","timestamp":1459179076000},"page":"1581-1588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study"],"prefix":"10.1016","volume":"13","author":[{"given":"Esther W.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallis C.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Wah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2016.03.049_bib1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults\u2014national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2016.03.049_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1160\/TH13-11-0948","article-title":"Stroke prevention in atrial fibrillation: an Asian perspective","volume":"111","author":"Chiang","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2016.03.049_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrcardio.2014.22","article-title":"Oral anticoagulants for Asian patients with atrial fibrillation","volume":"11","author":"Sabir","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"130","key":"10.1016\/j.hrthm.2016.03.049_bib4","first-page":"e199","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"2014","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2016.03.049_bib5","unstructured":"Use of aspirin for primary prevention of heart attack and stroke. U.S. Food and Drug Administration Web site. \u3008http:\/\/www.fda.gov\/drugs\/resourcesforyou\/consumers\/ucm390574.htm\u3009. Accessed May 10, 2015."},{"key":"10.1016\/j.hrthm.2016.03.049_bib6","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2016.03.049_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCULATIONAHA.111.031153","article-title":"New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation","volume":"125","author":"Ansell","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2016.03.049_bib8","unstructured":"Clusters, hospitals & institutions. The Hospital Authority. Web site. \u3008http:\/\/www.ha.org.hk\/visitor\/ha_visitor_text_index.asp?Content_ID=10036&Lang=ENG&Dimension=100&Parent_ID=10004&Ver=TEXT\u3009. Accessed June 11, 2015."},{"key":"10.1016\/j.hrthm.2016.03.049_bib9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa020546","article-title":"Influenza-related hospitalizations among children in Hong Kong","volume":"347","author":"Chiu","year":"2002","journal-title":"N Engl J Med"},{"issue":"586\u2013595","key":"10.1016\/j.hrthm.2016.03.049_bib10","first-page":"e583","article-title":"Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hrthm.2016.03.049_bib11","doi-asserted-by":"crossref","first-page":"h6926","DOI":"10.1136\/bmj.h6926","article-title":"Cardiovascular outcomes associated with use of clarithromycin: population based study","volume":"352","author":"Wong","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2016.03.049_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1542\/peds.2014-1738","article-title":"Methylphenidate and the risk of trauma","volume":"135","author":"Man","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.hrthm.2016.03.049_bib13","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/jac\/dku145","article-title":"An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study","volume":"69","author":"Chui","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.hrthm.2016.03.049_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40264-014-0209-0","article-title":"Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study","volume":"37","author":"He","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.hrthm.2016.03.049_bib15","doi-asserted-by":"crossref","unstructured":"Man KK, Ip P, Hsia Y, Chan EW, Chui CS, Lam MP, Wong WH, Chow CB, Yung A, Wong IC. ADHD drug prescribing trend is increasing among children and adolescents in Hong Kong [published online ahead of print July 3, 2014]. J Atten Disord. \u3008http:\/\/dx.doi.org\/10.1177\/1087054714536047\u3009.","DOI":"10.1177\/1087054714536047"},{"key":"10.1016\/j.hrthm.2016.03.049_bib16","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2016.03.049_bib17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"ACTIVE W Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2016.03.049_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control\u2014results from SPORTIF III and IV","volume":"167","author":"White","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2016.03.049_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2016.03.049_bib20","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.hrthm.2013.03.017","article-title":"Stroke prevention in atrial fibrillation\u2014an Asian stroke perspective","volume":"10","author":"Tse","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2016.03.049_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2008.05.042","article-title":"Epidemiology, risk factors for stroke, and management of atrial fibrillation in China","volume":"52","author":"Hu","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2016.03.049_bib22","unstructured":"Hong Kong Statistics: Population Estimates. Census and Statistics Department, The Government of the Hong Kong Special Adminstrative Region Web site. \u3008http:\/\/www.censtatd.gov.hk\/hkstat\/sub\/sp150.jsp?tableID=001&ID=0&productType=8\u3009. Accessed May 21, 2015."},{"key":"10.1016\/j.hrthm.2016.03.049_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.11-2888","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe","volume":"142","author":"Lip","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2016.03.049_bib24","unstructured":"Number of villages, neighborhoods, households and resident population. Ministry of the Interior, Republic of China (Taiwan) Web site. \u3008http:\/\/sowf.moi.gov.tw\/stat\/month\/elist.htm\u3009. Accessed May 21, 2015."},{"key":"10.1016\/j.hrthm.2016.03.049_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"10.1016\/j.hrthm.2016.03.049_bib26","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2016.03.049_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.acvd.2014.01.001","article-title":"RealiseAF Investigators. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey","volume":"107","author":"Gamra","year":"2014","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2016.03.049_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ahj.2012.02.008","article-title":"International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation","volume":"163","author":"Suarez","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2016.03.049_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2004.12.042","article-title":"Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China","volume":"105","author":"Wen-Hang","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2016.03.049_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1536\/jhj.42.55","article-title":"Underutilization of anticoagulation therapy in chronic atrial fibrillation","volume":"42","author":"Guo","year":"2001","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.hrthm.2016.03.049_bib31","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2016.03.049_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5414\/CP201996","article-title":"Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complications","volume":"52","author":"Liu","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2016.03.049_bib33","unstructured":"Hospital Authority Statistical Report 2012-2013. The Hospital Authority Web site. \u3008http:\/\/www.ha.org.hk\/upload\/publication_15\/491.pdf\u3009. Accessed November 27, 2014."},{"key":"10.1016\/j.hrthm.2016.03.049_bib34","unstructured":"Health Service Delivery Profile. Hong Kong (China). World Health Organization and Department of Health Hong Kong Web site. \u3008http:\/\/www.wpro.who.int\/health_services\/service_delivery_profile_hong_kong_%28china%29.pdf\u3009. Accessed January 30, 2015."}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527116301503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527116301503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T16:52:12Z","timestamp":1657731132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527116301503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1547527116301503"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2016.03.049","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2016.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Heart Rhythm Society. Published by Heart Rhythm Society All rights reserved.","name":"copyright","label":"Copyright"}]}}